Skip to main content
SERA logo

SERA · Sera Prognostics, Inc.

$2.03 -0.02 (-0.98%) At close · Jul 28
Market Cap
$79.49M
Shares
39.16M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.03 Open$2.03 Day$2.00–2.04 52W$1.56–3.95 Avg vol 30d39K Short int241K · 0.6% float · 6.8d Short vol35% Last earningsMay 6, 2026 DataJul 2021–Jul 2026 Filing10-Q · May 6

Up next

Next earnings call
Aug 9, 2026 Est · unconfirmed · in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 18.2 · elevated Equity put/call 0.71
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −20%
      below
      Price vs 50-day avg +2%
      above
      RSI (14) 50
      neutral
      MACD trend Positive
      52-week position 20%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +13%
      trailing
      6-month return −27%
      trailing
      YTD return −31%
      this year
      Relative strength −34%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $2 › 200d $3 — 200d above 50d
      Institutional flow Distributing
      7 of 56 funds reported for Jun 30 · net -2.7M sh shares
      Insider flow Distributing
      Net -$90.6K over 90 days · 100% sells
      Short interest Falling
      0.62% of float · ▼ -8.3% MoM · 6.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      56 holders — mid 3-yr range
      Squeeze score 56
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +5%
      Y/Y
      EPS growth +32%
      Y/Y
      Free cash flow $-26.3M
      Balance sheet $3.9M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 77%
      annualized · 1-yr
      Max drawdown −55%
      past year
      ATR 8.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the Earnings Call filed Mar 31, 2026
      Base operating expenses · annually $10M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −20% Bearish
      Price vs 50-day avg
      +2% Bullish
      RSI (14)
      50 Neutral
      MACD trend
      Positive Bullish
      52-week position
      20% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $2 › 200d $3 — 200d above 50d
      Institutional flow Distributing
      7 of 56 funds reported for Jun 30 · net -2.7M sh shares
      Insider flow Distributing
      Net -$90.6K over 90 days · 100% sells
      Short interest Falling
      0.62% of float · ▼ -8.3% MoM · 6.8 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      56 holders — mid 3-yr range
      Price context
      position in its 52-week range
      52-wk low $2 Now $2 · 20% 52-wk high $4
      vs 200-day avg -20% vs 50-day avg +2%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      SERA
      Sera Prognostics, Inc.
      this stock
      $79.49M -31.2% -74.8% 0.6%
      ABT
      Abbott Laboratories
      $186.84B -13.9% +5.7% 30.1 1.4%
      SYK
      Stryker Corp
      $132.87B -1.1% +11.2% 40.1 1.8%
      MDT
      Medtronic plc
      $111.21B -8.8% +8.4% 23.3 1.5%
      BSX
      Boston Scientific Corp
      $68.46B -51.7% +5.5% 19.3 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      54
      % held
      44.0%
      Reported
      7 of 56
      Top holder
      BAKER BROS. ADVISORS LP
      Held Float
      View
      Held by Funds
      Fund positions
      21
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      240.8K
      Days to cover
      6.8d
      Change
      -21.7K sh
      View
      Short Volume
      Short vol %
      35%
      As of
      Jul 28, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      2.0K
      Value
      $3.6K
      As of
      Jun 26, 2026
      View
      Off-Exchange
      Off-exchange %
      62.7%
      Week of
      May 4, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$90.6K
      Buyers / Sellers
      0 / 6
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $81.0K
      Net income (FY)
      $-31.9M
      EPS diluted
      $-0.67
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Jun 30, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $4.4K
      Shares
      2.2K
      Filed
      Jun 15, 2026
      View
      Exempt Offerings
      Offering
      $100.3M
      Filed
      May 11, 2021
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jun 3, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      SERA -3.3% +12.8% -27.0% +11.5% -31.2%
      SPY -1.0% 0.0% +7.4% -0.8% +8.6%
      vs SPY -2.3% +12.8% -34.4% +12.3% -39.8%
      Key facts CIK 1534969 CUSIP 81749D107 13F (30d) 6 filings 6 filers Visit website Investor relations